Jeffrey Wayne Faulk v. HHS - Hepatitis B, Guillain-Barre Syndrome (2022)

Wayne Stephen Faulk, as the legal representative of the Estate of Jeffrey Wayne Faulk, filed a petition for compensation under the National Vaccine Injury Compensation Program on February 22, 2017. The petition alleged that Jeffrey Wayne Faulk received a Hepatitis B vaccine on April 24, 2014, and subsequently suffered Guillain-Barre Syndrome (GBS) caused-in-fact by the vaccine.

The petition also stated that Mr. Faulk experienced residual effects for more than six months, that no prior award or settlement had been made, and that the vaccine was administered in the United States.

Jeffrey Wayne Faulk passed away on March 22, 2017, and the case proceeded as a claim for vaccine-related death. The respondent denied that the Hepatitis B vaccine caused the decedent's alleged GBS or any other injury, and denied that the alleged injury and eventual death were sequelae of a vaccine-related injury.

Despite these denials, the parties filed a joint stipulation for damages on May 3, 2022. Special Master Daniel T.

Horner reviewed the stipulation and found it reasonable, adopting it as the decision of the Court. The award consisted of a lump sum of $80,000.00, payable by check to the petitioner as the legal representative of the Estate of Jeffrey Wayne Faulk.

This amount was designated as compensation for all items of damages available under § 15(a). The public decision does not describe the onset of symptoms, specific clinical details, diagnostic tests, treatments, or the mechanism of causation.

Petitioner was represented by Milton Clay Ragsdale IV of Ragsdale LLC, and respondent was represented by Nina Ren of the U.S. Department of Justice.

The decision was issued on May 31, 2022.